Alpha BioMedical
We are a science-led biotech company with a special purpose to empower the lives of people through innovative research and development.
Vision
We envision a future of cancer-free society through our innovative R&D and technical excellence, empowering the lives of millions across the world.
Mission
To promote the wellness awareness by bringing differentiated and high-quality therapeutics, supported by our dedicated R&D, products, and services. We aim to empower people to live at their best that they can be. We are committed to the targeted areas of research leadership, innovation, and trust, providing a promising health enhancement solution for the future.
Our Lead Scientists & Clinician
Assistant Professor Dr. Shah Kwok Wei
Head of Scientific Team / Specialist in Developing Test Kits
Distinguished for his remarkable contributions to the field, Dr. Shah was honored with the prestigious distinction of being ranked within the “Top 2% of Scientists Worldwide in 2020 and 2021” by Stanford University. This exceptional acknowledgment stands as a testament to his profound expertise and significant impact within his areas of research, solidifying his position as a leading figure in the global scientific community.
Dr. Shah, a seasoned professional, has an extensive portfolio encompassing several significant roles and contributions across various international platforms. He has previously served as a dedicated lecturer for the Real Estate and Developers Association of Malaysia (REHDA GreenRE), a prominent organization in Malaysia. Additionally, he has played a crucial role as a PhD Co-Supervisor at the University Technology of Malaysia (UTM).
Notably, Dr. Shah’s expertise has transcended borders, as evidenced by his tenure as a Visiting Professor at both Tianjin University of Technology and, more recently, at Sichuan Agriculture University in China. His global impact is further underscored by his role as an Overseas Distinguished Visiting Professor at HCMC University of Technology in Ho Chi Minh, Vietnam.
At Alpha Biomedical, Dr. Shah leads the scientific team and spearheads the development of cutting-edge test kits designed to detect a spectrum of viruses, including the recent focus on COVID-19, alongside his pivotal role in advancing methodologies for cancer diagnostics
Dr. Koh Lam Son
Medical Advisor
Dr. Koh Lam Son boasts a distinguished career spanning over three decades, during which he has established himself as a leading figure in Obstetrics & Gynaecology, earning accolades for his thriving private practice in Singapore. Renowned as one of the country’s pioneering double board-certified O&G surgeons, Dr. Koh has facilitated the safe delivery of numerous healthy babies, leaving an indelible mark on the field.
In 2010, Dr. Koh’s professional trajectory took a transformative turn as he recognized the gaps within the healthcare system and experienced firsthand the impacts of contemporary lifestyle stressors. This realization prompted him to delve into the realm of Preventative Medicine, propelling him to attend various international conferences to acquire knowledge beyond the conventional scope of medical education. It was during this time that he cultivated a profound interest in the science of optimizing the aging process, incorporating these progressive techniques into both his professional practice and personal life, yielding commendable results.
Presently, Dr. Koh remains deeply committed to his practice, channeling his expertise towards pivotal areas such as hormones, cellular hydration and rejuvenation, women’s and men’s health, as well as supplementation and nutrition. By seamlessly integrating these specialized domains with his medical expertise, Dr. Koh continues to provide holistic care, emphasizing the significance of proactive health management and overall well-being.
Dr. Koh plays am advisory role at Alpha Biomedical, while also being active with medical affairs.
Dr. Susan Khin
Chief of Medical Affairs / Specialist in Clinical Trials
With a unique blend of current clinical expertise, comprehensive research methodology, and a commitment to evidence-based medicine, Dr. Khin brings forth a wealth of opportunities to address unmet clinical needs and explore new business prospects. Her extensive background spans the spectrum of clinical trial phases, including Early Phase – 1, Phase – 2, Phase – 3, and Phase – 4, allowing for a profound understanding of the intricacies involved in patient safety data review and Dose Escalation Studies.
Dr. Khin’s proficiency in comprehensive literature reviews and evidence-based research synthesis, coupled with ther scientific acumen, facilitates the meticulous conceptualisation of research hypotheses and the thorough analysis of Randomised Controlled Clinical Trial data.
Dr. Khin’s proficiency extends to advanced data analysis utilising complex Real-World data, facilitating the development of novel prognostic models, model validation, risk score algorithms, and health risk predictions. Overall, her expertise reflects a deep commitment to advancing evidence-based medical research and ensuring the highest standards of clinical excellence.
Dr. Khin holds the esteemed position of Chief of Medical Affairs at Alpha Biomedical, where she plays a pivotal role in overseeing the strategic direction of medical initiatives. In addition, she actively contributes to the coordination and management of various clinical trials.
Dr. Sundramurthy Kumar
Advisor / Specialist in Cancer Research
Dr. Kumar excels in leading research and development initiatives, specializing in pre-clinical, clinical, basic, and advanced research, and possessing an in-depth understanding of research strategy and facilities management. His adeptness extends to senior management roles, where he effectively oversees a diverse array of portfolios encompassing research administration, general administration, research support, finance, procurement, budgeting, and human resources.
Furthermore, Dr. Kumar displays remarkable proficiency in operations, management, and public relations, with a comprehensive grasp of business continuity management (BCM) and health, safety, and environment (HSE). His proven expertise in risk management, business development, logistics, and finance enables him to offer pragmatic insights and effective solutions across diverse business domains, ensuring operational excellence and strategic success.
Moreover, Dr. Kumar is a persuasive and articulate communicator, adept at cultivating strong relationships with a variety of stakeholders, including vendors, development teams, users, and executives. Notably, his exceptional skill in streamlining processes significantly contributes to fostering sustainable business and organizational growth, further solidifying his reputation as a versatile and accomplished professional in his field.
Based on his extensive tenure as a Research Fellow in Immunology at the prestigious Memorial Sloan Kettering Cancer Center in New York, Dr. Kumar has been appointed as an esteemed advisor at Alpha Biomedical. His invaluable experience and expertise makes him an invaluable member when it comes to the R&D of Cells and Immunotherapy.
Dr. Wijenthiran Kunasekaran
Senior Scientist / Specialist in Stem Cell and Exosome Research
The professional journey of Dr. Wijenthiran is underscored by a profound dedication to the fields of science and biotechnology, evident through a robust skill set that includes expertise in mammalian cell culture. This proficiency has been instrumental in spearheading groundbreaking research endeavors, leading to several significant contributions in the form of noteworthy publications and patents.
Notably, Dr. Wijenthiran has conducted pioneering comparative analyses of cardiovascular development-related genes in stem cells derived from deciduous pulp and adipose tissue, shedding light on crucial scientific insights. Additionally, the cloning and characterization of the ACC Oxidase gene from Mas (AA) Banana and the exploration of immunomodulatory properties in dental pulp stem cells derived from both healthy and inflamed teeth have cemented Dr. Wijenthiran’s reputation as an accomplished researcher.
Dr. Wijenthiran’s role as a patent holder for Stem Cell Conditioned Media and the pioneering work on the isolation, expansion, and characterisation of Wharton’s Jelly Mesenchymal Stem Cells highlights their innovative approach and significant impact in the field of biotechnology.